Ascend Wellness Holdings (AAWH) Assets Average (2021 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Assets Average of $890.0 million in Q1 2026, down 1.56% quarter-over-quarter from $904.1 million in Q4 2025, and down 2.04% on a YoY basis from $908.6 million in Q1 2025.
Ascend Wellness Holdings (AAWH) Assets Average (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Assets Average history runs 6 years deep, the most recent figure standing at $890.0 million for Q1 2026.
- In Q1 2026, Assets Average fell 2.04% year-over-year to $890.0 million; the TTM figure through Mar 2026 stood at $890.0 million (down 2.04% YoY), while the FY2025 annual figure was $904.2 million, down 0.64% from the prior year.
- Assets Average was $890.0 million for Q1 2026 at Ascend Wellness Holdings, down from $904.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $925.6 million in Q2 2024 to a low of $718.8 million in Q1 2022.
- Historically, Assets Average has averaged $878.5 million across 5 years, with a median of $902.1 million in 2025.
- The sharpest annual moves came in 2022 and 2026: Assets Average soared 58.15% in 2022, then dropped 2.04% in 2026.
- A 5-year view of Assets Average shows it stood at $859.7 million in 2022, then advanced by 6.29% to $913.8 million in 2023, then retreated by 1.71% to $898.2 million in 2024, then grew by 0.67% to $904.1 million in 2025, then declined by 1.56% to $890.0 million in 2026.
- The last three Assets Average figures came in at $890.0 million (Q1 2026), $904.1 million (Q4 2025), and $902.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | 890.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 890.01 Mn |
| Dec 31, 2025 | 904.15 Mn |
| Sep 30, 2025 | 902.11 Mn |
| Jun 30, 2025 | 910.30 Mn |
| Mar 31, 2025 | 908.58 Mn |
| Dec 31, 2024 | 898.15 Mn |
| Sep 30, 2024 | 912.62 Mn |
| Jun 30, 2024 | 925.61 Mn |
| Mar 31, 2024 | 920.70 Mn |
| Dec 31, 2023 | 913.77 Mn |
| Sep 30, 2023 | 903.77 Mn |
| Jun 30, 2023 | 884.82 Mn |
| Mar 31, 2023 | 871.12 Mn |
| Dec 31, 2022 | 859.69 Mn |
| Sep 30, 2022 | 838.00 Mn |
| Jun 30, 2022 | 771.50 Mn |
| Mar 31, 2022 | 718.82 Mn |
| Dec 31, 2021 | 720.16 Mn |
| Sep 30, 2021 | 647.82 Mn |
| Jun 30, 2021 | 530.03 Mn |